‡ In these countries please contact our distributor

CLOSER TO ZERO wound biofilm

The information on this website is intended for healthcare professionals outside of the US only


IODOSORB 0.9% cadexomer iodine dressings can disrupt biofilm through highly absorptive microbeads and a sustained antimicrobial action, promoting autolytic debridement1,4-5,8,12


Stalled diabetic foot ulcers

Significant reduction in biofilm bacteria after 7 days, without prior sharp debridement2

Download summary PDF (Malone, effect of cadexomer Iodine)


Effective against biofilm

Independent data demonstrates IODOSORB’s anti-biofilm efficacy6

Read more (Schultz & Yang poster)


A multi-faceted, step down approach to managing biofilm in stalled chronic wounds3

Download summary PDF (Schultz)


Resistant venous leg ulcers

RCT demonstrates IODOSORB usage can offer significantly greater cleansing effect, compared with standard care4

Read full study (Skog E, et al)

Exudate absorption

Cadexomer iodine microbeads could provide a significant reduction in exudate in venous leg ulcers, compared with standard care5

Read full study (Troeng)


Faster healing potential

This positive Cochrane review demonstrates anti-biofilm efficacy and faster healing rates7

Read full study (O’Meara Cochrane Database)

Antimicrobial against biofilm.

IODOSORB’s cadexomer microbeads can effectively dehydrate and destroy exposed biofilm bacteria8

Read full study (Akiyama)


Pressure ulcer slough reduction.

A RCT that demonstrates a significant reduction in pus and debris9

Read full study (Moberg)

Slough in venous leg ulcers

A 12-week RCT showing significantly reduced slough at 4 and 8 weeks, compared with paraffin gauze10

Read full study (Hansson)


Anti-bacterial efficacy.

A diabetic foot ulcer cohort study demonstrating a statistically significant median reduction in bacterial load, at 3 and 6 weeks, compared to baseline11

Read full study (Schwartz)

For further information about IODOSORB, download our full product brochure.

Contact us to discuss your requirements.


1. Smith & Nephew data on file, 2009 #091101
2. Malone, M. et al. Effect of Cadexomer Iodine on the microbial load and diversity of chronic non-healing diabetic foot ulcers complicated by biofilm in vivo. J. Antimicrob. Chemother. Epub ahead of print, (2017)
3. Schultz, G. et al. Consensus guidelines for the identification and treatment of biofilms in chronic non-healing wounds. Wound Repair Regen. Submitted, (2017).
4. Skog E, Arnesjo B, Troeng T, et al. Br J Dermatol. 109:77-83 (1983)
5. Troeng T, Skog E, Arnesjo B, et al in Fox JA, Fischer H, eds. Cadexomer Iodine. New York, NY: FK Schattauer Verlag: 43-50 (1983).
6. Schultz G & Yang. Poster presented at WUWHS Florence (2016)
7. O’Meara S, et al. Cochrane database Syst. Rev. 1,CD003557 (2014)
8. Akiyama H, et al. J. Dermatol. 31, 529-34 (2004)
9. Moberg S, et al. J. Am. Geriatr. Soc (1983)
10. Hansson C. Int. J. Dermatol. 37:390-396 (1998)
11. Schwartz J a, et al, INt. Wound J. 10, 193-9 (2013)
12. Hill E, et al, J Antimicrob. Chemother. 1195-1206 (2010)

IODOSORB anti-biofilm, antimicrobial 0.9% cadexomer iodine dressings.


Find out more